VENTOLIN EVOHALER 100 MCG [SIN11359P]

Product Info

VENTOLIN EVOHALER 100 MCG

[SIN11359P]

Indications

Pharmaceutical form: Pressurised inhalation, suspension.

VENTOLIN Evohaler provides short-acting (4 to 6 hours) bronchodilation with fast onset (within 5 minutes) in reversible airways obstruction.

It is particularly suitable for the relief and prevention of asthma symptoms.

VENTOLIN Evohaler should be used to relieve symptoms when they occur, and to prevent them in those circumstances recognised by the patient to precipitate an asthmatic attack (e.g. before exercise or unavoidable allergen exposure).

VENTOLIN Evohaler is particularly valuable as relief medication in mild, moderate or severe asthma, provided that reliance on it does not delay the introduction and use of regular inhaled corticosteroid therapy.

Salbutamol is a selective beta-2 adrenoceptor agonist indicated for the treatment and prevention of bronchospasm. It provides short acting (4 hours) bronchodilation in reversible airways obstruction. For patients with asthma salbutamol may be used to relieve symptoms when they occur and to prevent them prior to a known trigger.

Bronchodilators should not be the only or main treatment in patients with persistent asthma. In patients with persistent asthma unresponsive to VENTOLIN, treatment with inhaled corticosteroids is recommended to achieve and maintain control. Failing to respond to treatment with VENTOLIN may signal a need for urgent medical advice or treatment.

Dosage and Administration

VENTOLIN Evohaler is administered by the oral inhaled route only.

VENTOLIN has a duration of action of 4 to 6 hours in most patients.

Increasing use of beta-2 agonists may be a sign of worsening asthma. Under these conditions a reassessment of the patient's therapy plan may be required and concomitant corticosteroid therapy should be considered.

In patients who find co-ordination of a pressurised metered-dose inhaler difficult, a Volumatic spacer may be used with VENTOLIN Evohaler.

Babies and young children using the VENTOLIN Evohaler may benefit from the use of a paediatric spacer device with a face mask.

As there may be adverse effects associated with excessive dosing, the dosage or frequency of administration should only be increased on medical advice.

RELIEF OF ACUTE BRONCHOSPASM

• Adults

  100 or 200 mcg.

• Children

  100 mcg. The dose may be increased to 200 mcg if required.

PREVENTION OF ALLERGEN OR EXERCISE-INDUCED BRONCHOSPASM

• Adults

  200 mcg before challenge or exertion.

• Children

  100 mcg before challenge or exertion. The dose may be increased to 200 mcg if required.

CHRONIC THERAPY

• Adults

  Up to 200 mcg 4 times daily.

• Children

  Up to 200 mcg 4 times daily.

On demand use of VENTOLIN should not exceed four times daily. Reliance on such supplementary use or a sudden increase in dose indicates deteriorating asthma (see Warnings and Precautions – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

Contraindications

VENTOLIN is contraindicated in patients with a history of hypersensitivity to any of its components. Non-i.v. formulations of VENTOLIN must not be used to arrest uncomplicated premature labour or threatened abortion.